Abstract
Previous work in this laboratory (Kerry, Hamilton-Miller and Brumfitt 1975a,b) has shown that a combination of rifampicin (rif) and trimethoprim(tm) will inhibit virtually all common pathogenic bacteria. The combination has the added advantage of acting synergistically against several genera, notably streptococci and all species of proteus. Secondly, it suppresses the emergence of resistance to rifampicin. In view of these encouraging findings, we have now undertaken a pharmacokinetic study to determine whether rif and tm interfere with one another’s handling in man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acocella, G., Pagani, V., Marchetti, M., Baroni, G.C. & Nicolis, F. B. 1971 Chemotherapia, 16, 356.
Binda, G., Domenichini, E., Gottardi, A., Orlandi, B., Ortelli, E., Pacini, B. & Fowst, G. 1971 Arzneimitt.Forsch., 21, 1907.
Furesz, S. 1970 Antibiot.Chemother. (Basel), 26, 316.
Kerry, D.W., Hamilton-Miller, J.M.T. & Brumfitt, W. 1975a J. Antimicrob.Chemother., 1 in press.
Kerry, D.W., Hamilton-Miller, J.M.T. & Brumfitt, W. 1975b These Proceedings.
Schwartz, D.E. & Rieder, J. 1970 Chemotherapia, 15, 337.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Brumfitt, W., Moss, V.M., Brooker, E., Hamilton-Miller, J.M.T. (1976). A Pharmacokinetic Study of the Combination Rifampicin Plus Trimethoprim in Man. In: Williams, J.D., Geddes, A.M. (eds) Pharmacology of Antibiotics. Chemotherapy, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3123-0_32
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3123-0_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3125-4
Online ISBN: 978-1-4684-3123-0
eBook Packages: Springer Book Archive